Journal of Clinical Endocrinology & Metabolism, Vol 80, 21-27, Copyright © 1995 by Endocrine Society

ARTICLES

Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy

KS Langford, KH Nicolaides, J Jones, A Abbas, AM McGregor and JP Miell
Department of Medicine, King's College School of Medicine and Dentistry, London, United Kingdom.

Proteolytic activity directed against insulin-like growth factor (IGF)- binding protein-3 (IGFBP-3) is found in human pregnancy serum. We have investigated changes in this protease activity in pregnancies in which the fetus is small for gestational age and in multiple pregnancies. Maternal serum was obtained from 18 singleton pregnancies at 27 weeks gestational age (GA), and matched fetal serum was collected by cordocentesis. Fetuses were appropriate for GA (AGA; n = 6), small for gestational age (SGA) with evidence of uteroplacental insufficiency (UPI; starved SGA; n = 6), or SGA without UPI (nonstarved SGA; n = 6). In a second study, serum was obtained from women with singleton (n = 10), twin (n = 10), and higher multiple pregnancies (n = 10) at 9 weeks GA. All women with more than three fetuses underwent embryo reduction to 2 fetuses before 15 weeks gestation, when a second serum sample was obtained. Circulating IGF-I and IGF-II were measured by RIA, and IGFBP- 3 was measured by both RIA and immunoradiometric assay. IGFBP-3 protease activity was assessed by Western ligand blotting after incubation with a normal nonpregnancy sera pool, immunoblotting, and specific protease assay. In the growth study, circulating maternal IGF- I and IGFBP-3 levels were not different in the three groups, but fetal IGF-I and IGFBP-3 levels were significantly lower in the UPI fetuses (IGF-I, 6.9 +/- 0.5 micrograms/L; IGFBP-3, 547 +/- 70 micrograms/L) than in either the nonstarved SGA fetuses (IGF-I, 27.8 +/- 6.3; IGFBP- 3, 769 +/- 41 micrograms/L; P < 0.01) or the AGA fetuses (IGF-I, 39.4 +/- 3.4; IGFBP-3, 872 +/- 91 micrograms/L; P < 0.01). Maternal serum IGFBP-3 protease activity, measured by protease using [125I]IGFBP-3 as substrate, was increased in pregnancies complicated by UPI compared with GA-matched pregnancies in which the fetus was AGA or nonstarved SGA. No significant fetal serum protease activity was demonstrated. In the multiple pregnancies, IGFBP-3 rose significantly from 9-15 weeks GA in singleton (P = 0.005), twin (P = 0.004), and multiple (P = 0.007) pregnancies, and levels were higher in mothers of multiple pregnancies than in those of twin (P < 0.05) or singleton (P < 0.01) pregnancies at both 9 and 15 weeks GA. IGF-I levels were not different in the three groups and did not significantly increase between 9-15 weeks GA.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				P. Saenger, P. Czernichow, I. Hughes, and E. O. Reiter Small for Gestational Age: Short Stature and Beyond Endocr. Rev., April 1, 2007; 28(2): 219 - 251. [Abstract] [Full Text] [PDF]

				V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF]

				J. Laigaard, T. Sorensen, S. Placing, P. Holck, C. Frohlich, K. R. Wojdemann, K. Sundberg, A.-C. Shalmi, A. Tabor, B. Norgaard-Pedersen, et al. Reduction of the Disintegrin and Metalloprotease ADAM12 in Preeclampsia Obstet. Gynecol., July 1, 2005; 106(1): 144 - 149. [Abstract] [Full Text] [PDF]

				P. J. Pringle, M. P. P. Geary, C. H. Rodeck, J. C. P. Kingdom, S. Kayamba-Kay's, and P. C. Hindmarsh The Influence of Cigarette Smoking on Antenatal Growth, Birth Size, and the Insulin-Like Growth Factor Axis J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2556 - 2562. [Abstract] [Full Text] [PDF]

				M. Chellakooty, K. Vangsgaard, T. Larsen, T. Scheike, J. Falck-Larsen, J. Legarth, A. M. Andersson, K. M. Main, N. E. Skakkebaek, and A. Juul A Longitudinal Study of Intrauterine Growth and the Placental Growth Hormone (GH)-Insulin-Like Growth Factor I Axis in Maternal Circulation: Association between Placental GH and Fetal Growth J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 384 - 391. [Abstract] [Full Text] [PDF]

				M. P. P. Geary, P. J. Pringle, C. H. Rodeck, J. C. P. Kingdom, and P. C. Hindmarsh Sexual Dimorphism in the Growth Hormone and Insulin-Like Growth Factor Axis at Birth J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3708 - 3714. [Abstract] [Full Text] [PDF]

				H. G. Skinner, D. S. Michaud, G. A. Colditz, E. L. Giovannucci, M. J. Stampfer, W. C. Willett, and C. S. Fuchs Parity, Reproductive Factors, and the Risk of Pancreatic Cancer in Women Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 433 - 438. [Abstract] [Full Text] [PDF]

				F. F. Lauszus, J. G. Klebe, T. Bek, and A. Flyvbjerg Increased Serum IGF-I During Pregnancy Is Associated With Progression of Diabetic Retinopathy Diabetes, March 1, 2003; 52(3): 852 - 856. [Abstract] [Full Text] [PDF]

				F. F. LAUSZUS, J. G. KLEBE, and A. FLYVBJERG Macrosomia Associated With Maternal Serum Insulin-Like Growth Factor-I and -II in Diabetic Pregnancy Obstet. Gynecol., May 1, 2001; 97(5): 734 - 741. [Abstract] [Full Text] [PDF]

				J. C. Irwin, L.-F. Suen, B.-H. Cheng, R. Martin, P. Cannon, C. L. Deal, and L. C. Giudice Human Placental Trophoblasts Secrete a Disintegrin Metalloproteinase Very Similar to the Insulin-Like Growth Factor Binding Protein-3 Protease in Human Pregnancy Serum Endocrinology, February 1, 2000; 141(2): 666 - 674. [Abstract] [Full Text] [PDF]

				R.P. Holmes, J.M.P. Holly, and P.W. Soothill Maternal serum insulin-like growth factor binding protein-2 and -3 and fetal growth Hum. Reprod., July 1, 1999; 14(7): 1879 - 1884. [Abstract] [Full Text] [PDF]

				S. Cianfarani, D. Germani, and F. Branca Low birthweight and adult insulin resistance: the "catch-up growth" hypothesis Arch. Dis. Child. Fetal Neonatal Ed., July 1, 1999; 81(1): 71F - 73. [Full Text]

				C. Skjærbæk, A. Kaal, J. Møller, N. Vahl, J. Weeke, H. Ørskov, and A. Flyvbjerg No Effect of Growth Hormone on Serum Insulin-Like Growth Factor Binding Protein-3 Proteolysis J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1206 - 1210. [Abstract] [Full Text]

				S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text]

				P Pirazzoli, E Cacciari, R De Iasio, M C Pittalis, P Dallacasa, S Zucchini, S Gualandi, S Salardi, C David, and S Boschi Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3 Arch. Dis. Child. Fetal Neonatal Ed., September 1, 1997; 77(2): 100F - 104. [Abstract] [Full Text]

				J. P. Miell, K. S. Langford, J. S. Jones, P. Noble, M. Westwood, A. White, and K. H. Nicolaides The Maternal Insulin-Like Growth Factor (IGF) and IGF-Binding Protein Response to Trisomic Pregnancy during the First Trimester: A Possible Diagnostic Tool for Trisomy 18 Pregnancies J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 287 - 292. [Abstract] [Full Text] [PDF]